ATC code None PubChem CID 51049972 UNII 1P85D6BE9K Molar mass 377.825 g/mol | CAS Number 503294-13-1 ChemSpider 25948207 Formula C17H20ClN5O3 | |
 | ||
Dasolampanel (INN, USAN, code name NGX-426) is an orally bioavailable analog of tezampanel and thereby competitive antagonist of the AMPA and kainate receptors which was under development by Raptor Pharmaceuticals/Torrey Pines Therapeutics for the treatment of chronic pain conditions including neuropathic pain and migraine. It was developed as a follow-on compound to tezampanel, as tezampanel is not bioavailable orally and must be administered by intravenous injection, but ultimately neither drug was ever marketed.
References
Dasolampanel Wikipedia(Text) CC BY-SA